Results 91 to 100 of about 5,671 (151)

Efficacy and safety of darolutamide <i>versus</i> abiraterone acetate plus prednisone in combination with ADT for mHSPC: a real-world clinical retrospective study. [PDF]

open access: yesFront Pharmacol
Hu T   +13 more
europepmc   +1 more source

Efficient Process Development of Abiraterone Acetate by Employing Design of Experiments. [PDF]

open access: yesACS Omega
Komati SK   +7 more
europepmc   +1 more source

Immunohistochemical Analysis of Androgen Receptor Expression Predicts the Prognosis of Metastatic Castration-Sensitive Prostate Cancer Patients Receiving Abiraterone Acetate. [PDF]

open access: yesProstate
Nishimoto M   +14 more
europepmc   +1 more source

Abiraterone acetate, an inhibitor of adrenal androgen synthesis in "hormone refractory prostate cancer"

open access: yesIndian Journal of Medical and Paediatric Oncology, 2011
Arun Kumar Goel, Sudarsan De
doaj   +1 more source

Treatment switching between Enzalutamide and Abiraterone Acetate and time to oral opioid initiation in castration-resistant prostate cancer patients. [PDF]

open access: yesCancer Epidemiol
Asiri IM   +12 more
europepmc   +1 more source

Abiraterone Acetate Versus Enzalutamide Against Chemo-Naïve Castration-Resistant Prostate Cancer With Full-Dose Induction. [PDF]

open access: yesCureus
Shimomura T   +9 more
europepmc   +1 more source

Compatibility of hypokalaemia caused by low-dose prednisolone plus abiraterone acetate therapy for metastatic castration-resistant prostate cancer. [PDF]

open access: yesJ Pharm Health Care Sci
Torii S   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy